Cary Street Partners Investment Advisory LLC Takeda Pharmaceutical CO LTD Transaction History

Cary Street Partners Investment Advisory LLC

$2.63 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$15.28 - $16.48 $61 - $65	-4 Reduced 0.58%	687 $11,000
Q4 2022 Feb 14, 2023	BUY	$12.42 - $15.62 $8,582 - $10,793	691 New	691 $10,000
Q4 2020 Feb 12, 2021	SELL	$15.39 - $18.97 $1,769 - $2,181	-115 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$17.1 - $19.19 $1,966 - $2,206	115 New	115 $2,000

Others Institutions Holding TAK

# of Institutions

337

Shares Held

73.8M

Call Options Held

1.96M

Put Options Held

165K

Capital Research Global Investors Los Angeles, CA

13.1M
Shares

$178 Million
0.04% of portfolio
Morgan Stanley New York, NY

5.35M
Shares

$72.6 Million
0.01% of portfolio
Mondrian Investment Partners LTD London, X0

5.09M
Shares

$69.1 Million
1.21% of portfolio
Arrowstreet Capital, Limited Partnership Boston, MA

4.64M
Shares

$62.9 Million
0.05% of portfolio
Goldman Sachs Group Inc New York, NY

4.56M
Shares

$61.8 Million
0.01% of portfolio

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Investment Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Investment Advisory LLC with notifications on news.

Account